EMILY DUEZ: Open Payments
NPI 1134790298 · YOUNGSTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,522 in 134 payments from 19 companies in 2025. Trend: 2023 $2,151 · 2024 $2,032 · 2025 $2,522
Food & beverage: $2,488Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 29 | $752 |
| GlaxoSmithKline, LLC. | 39 | $458 |
| Regeneron Healthcare Solutions, Inc. | 12 | $351 |
| Electromed, Inc. | 10 | $157 |
| GENZYME CORPORATION | 11 | $154 |
| Verona Pharma, Inc. | 5 | $107 |
| Amgen Inc. | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $68 |
| United Therapeutics Corporation | 3 | $60 |
| Viatris Specialty LLC | 3 | $56 |
Products named: DUPIXENT, NUCALA, FASENRA, TEZSPIRE, SMARTVEST, TRELEGY ELLIPTA, Ohtuvayre, BREZTRI.
Industry payments across OH — which companies pay providers there.
